John W. Day, MD, PhD

Publication Details

  • Spinocerebellar ataxia type 5. Handbook of clinical neurology Dick, K. A., Ikeda, Y., Day, J. W., Ranum, L. P. 2012; 103: 451-459


    In 1994, Ranum and colleagues identified a ten-generation American kindred with a relatively mild autosomal dominant form of spinocerebellar ataxia (Ranum et al., 1994). The mutation was mapped to the centromeric region of chromosome 11, and the disorder designated SCA5 (Ranum et al., 1994). Using a multifaceted mapping approach, Ikeda et al. (2006) discovered that ?-III spectrin (SPTBN2) mutations cause spinocerebellar ataxia type 5 (SCA5) in the American kindred and two additional independently reported SCA5 families. The American and French families have separate in-frame deletions of 39 and 15 bp, respectively, in the third of 17 spectrin repeat motifs. A third mutation, found in a German family, is located in the second calponin homology domain, a region known to bind actin and Arp1. Consistent with Purkinje cell degeneration in SCA5, ?-III spectrin is highly expressed in cerebellar Purkinje cells. TIRF microscopy performed on cell lines transiently transfected with mutant or wild-type spectrin shows that mutant ?-III spectrin fails to stabilize the glutamate transporter EAAT4 at the plasma membrane. Additionally, marked differences in EAAT4 and GluR?2 were found by protein blot and cell fractionation in SCA5 autopsy tissue. This review summarizes data showing that ?-III spectrin mutations are a novel cause of neurodegenerative disease, which may affect the stabilization or trafficking of membrane proteins.

    View details for DOI 10.1016/B978-0-444-51892-7.00028-0

    View details for PubMedID 21827906

Stanford Medicine Resources:

Footer Links: